Fresh Tracks Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
FRTX on OTC
Location
2000 Central Avenue, Suite 100, Boulder, CO

Insiders trading volume in the past year

Fresh Tracks Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Exploration Capital, LLC 10%+ Owner $1.64M +$1M +158% Jun 7, 2024
Exploration Capital Fund, LP 10%+ Owner $693K -$26.4K -3.66% Dec 4, 2023
Andrew Sklawer President and CEO $38.9K Oct 2, 2023
Deepak Chadha Former Chief R&D Officer & COO $22.1K Sep 1, 2023
David R. McAvoy Gen Counsel, CCO, & Secretary $16.2K Oct 2, 2023
Jose Breton Chief Accounting Officer May 5, 2022
Dennison T. Veru Director May 17, 2022
Gary A. Lyons Director May 17, 2022
Vijay B. Samant Director May 17, 2022
Reginald L. Hardy CHAIRMAN OF THE BOARD, Director May 17, 2022
Monica Luchi Chief Medical Officer May 5, 2022
Robert B. Brown Chief Executive Officer, Director May 5, 2022
Aaron Fox-Collis VP of Finance & CAO -$98 Dec 28, 2023
Albert N. Marchio II CEO and CFO, Director Dec 28, 2023

Recent Insider Transactions by Companies or Individuals for Fresh Tracks Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.